| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 39.45 | 43.7% |
| Total Income | 40.24 | 43.7% |
| Expenditure | 40.93 | 37.0% |
| PBT | -0.69 | 110.6% |
| Net Profit | 0.02 | 99.7% |
| OPM | 3.24% | 8.28pp |
| NPM | 0.05% | 8.62pp |
| EPS | 0.03 | 99.6% |
Dai-Ichi Karkaria Ltd. Reports QT FY25-26 Results with Enhanced Collaboration and Innovation
07 Aug 2025 · 7 Aug 2025, 03:59 pm
Summary
Dai-Ichi Karkaria Ltd., a specialty chemicals company, has reported its QT FY25-26 results. The company has a strong focus on sustainability, innovation, and quality control. It has a history of partnerships and collaborations, including a recent joint venture with GVK Biosciences for the manufacture of chemical sector oilfield chemicals.
Key Highlights
- 1
Commenced production in 1963 in technical collaboration with Dai-ichi Kogyo Seiyaku based in Japan
- 2
Develop and manufacture high-performance speciality chemicals for various industrial applications
- 3
Market innovative products, providing custom solutions tailored to our client’s needs
- 4
Work towards creating products and processes that are clean, reflecting the integrity of our manufacturing process
- 5
Minimum use of hazardous chemicals and efficient chemical synthesis
- 6
Rigorous, regular and complete testing at every stage
- 7
Conform to all relevant health, safety, environmental, national, and international standards
- 8
Focus on product design, process efficiency and environmental health & safety
- 9
Integrating new technologies and sustainable practices
- 10
Reduce environmental impact while enhancing product performance
- 11
Created a JV with GVK Biosciences for the manufacture of oilfield chemicals in the Indian oil field upstream sector
Management Comments
Ankit Ankit Parimal Shah
Please find enclosed herewith the Results Presentation of the Company for the period ended June 30, 2025, for your records and the same will be placed on the website of the Company i.e. http://www.dai- ichiindia.com/investors
Informational and educational content only. Not investment advice.